April 25, 2017 1:17 PM ET

Healthcare Equipment and Supplies

Company Overview of Ortho-Clinical Diagnostics, Inc.

Company Overview

Ortho-Clinical Diagnostics, Inc. provides in vitro diagnostics solutions to clinical laboratories and immunohematology communities worldwide. It offers chemistry and immunodiagnostics solutions, which include integrated chemistry systems, chemistry systems, immunodiagnostic systems, laboratory automation and middleware solutions, and acute kidney injury-acute renal failure testing devices and meters; and transfusion medicine solutions, including immunohematology analyzers, workstations, and reagents, as well as donor screening solutions. The company also provides predictive technologies, inventory management, laboratory optimization, and training and education services. Its portfolio of prod...

1001 US 202

Raritan, NJ 08869

United States

Founded in 1974





Key Executives for Ortho-Clinical Diagnostics, Inc.

Chairman and Chief Executive Officer
Age: 56
Chief Financial Officer
Age: 48
Chief Operating Officer and Executive Vice President
Executive Vice President and General Counsel
Executive Vice President of Commercial Operations
Compensation as of Fiscal Year 2016.

Ortho-Clinical Diagnostics, Inc. Key Developments

Wuhan Thalys Medical Technology Inc. Enters into Agreement with Ortho-Clinical Diagnostics Inc

Wuhan Thalys Medical Technology Inc. has entered into an agreement with Ortho-Clinical Diagnostics Inc. Under the agreement, Ortho-Clinical Diagnostics will provide medical instruments to Wuhan Thalys Medical Technology.

Ortho Clinical Diagnostics Announces Expansion of Global Agreement with Astute Medical for NephroCheck Test

Ortho Clinical Diagnostics announced that it has expanded its agreement with Astute Medical, Inc. for distribution of the NephroCheck Test, a biomarker-based test that aids in risk assessment for acute kidney injury. Under the new agreement, Astute Medical has granted Ortho distribution rights in additional European countries, enhancing customer access to a test that is changing the way hospital physicians approach acute kidney injury (AKI), a common and dangerous complication.

Ortho-Clinical Diagnostics, Inc. Presents at 35th Annual JP Morgan Healthcare Conference, Jan-10-2017 04:00 PM

Ortho-Clinical Diagnostics, Inc. Presents at 35th Annual JP Morgan Healthcare Conference, Jan-10-2017 04:00 PM. Venue: Westin St. Francis Hotel, 335 Powell Street, San Francisco, CA 94102, United States. Speakers: Martin D. Madaus, Chairman and Chief Executive Officer.

Similar Private Companies By Industry

Company Name Region
.decimal, Inc. United States
20/20 GeneSystems, Inc. United States
20/20 Imaging LLC United States
21st Century Scientific, Inc. United States
21X Corporation United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Ortho-Clinical Diagnostics, Inc., please visit www.orthoclinical.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.